Related Experiment Video

Updated: Jun 5, 2026

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
09:56

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

Published on: October 31, 2025

The promise of epigenetics in personalized medicine

Wendell W Weber1

  • 1Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109-5632, USA. wwweber@umich.edu

Molecular Interventions
|January 26, 2011
PubMed

Insights

Targeting aberrant epigenetic marks shows promise for treating myelodysplastic syndromes, leukemic syndromes, and hemoglobinopathies. Advances in sequencing and gene expression analysis are improving our understanding of epigenetic regulation for personalized medicine.

Area of Science:

  • Epigenetics
  • Genomics
  • Molecular Medicine

Background:

  • Aberrant epigenetic marks are implicated in various human disorders, including myelodysplastic syndromes, leukemic syndromes, and hemoglobinopathies.
  • Targeting these epigenetic alterations represents a potential therapeutic strategy.

Purpose of the Study:

  • To review the evidence supporting epigenetic mark targeting for disease prevention and treatment.
  • To highlight advancements in epigenetic mapping and their implications for personalized medicine.

Main Methods:

  • Preclinical and clinical trials utilizing existing and novel drugs targeting epigenetic modifications.
  • Advancements in sequencing technologies, including chromatin immunoprecipitation and gene expression analyses, for precise epigenetic mapping.

Main Results:

  • Demonstrated efficacy of targeting aberrant epigenetic marks in preclinical and clinical settings.
  • Substantial progress in understanding gene regulation, promoter regions, and chromatin organization in health and disease.

Conclusions:

  • Targeting epigenetic marks is a viable therapeutic approach for specific human disorders.
  • Emerging insights into epigenetic drug targets pave the way for personalized medicine strategies.

More Related Videos

Methylated DNA Immunoprecipitation21:24

Methylated DNA Immunoprecipitation

Published on: January 2, 2009

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...